Live attenuated varicella vaccine for prevention of herpes zoster

Biologicals

Volumn 25, Issue 2, 1997, Pages 227-230

  Gershon, A ^a   Silverstein, S ^a  

^a Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHICKENPOX VACCINE; LIVE VACCINE;

ADOLESCENT; ADULT; CHILD; CONFERENCE PAPER; HERPES ZOSTER; HUMAN; PRIORITY JOURNAL;

HERPES; HERPES ZOSTER;

EID: 0031171009     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1006/biol.1997.0089     Document Type: Conference Paper

References (24)

1. 1. Gershon A. Varicella-zoster virus: prospects for control. Adv Ped Infect Dis 1995; 10: 93-124.
2. 2. Cohrs RJ, Harbour M, Gilden DH. Varicella-zoster virus (VZV) transcription during latency in human ganglia: detection of transcripts to genes 21, 29, 62, and 63 in a cDNA library enriched for VZV RNA. J Virol 1996; 70: 2789-2796.
3. 3. Lungu O, Annunziato P, Gershon A et al. Reactivated and latent varicella-zoster virus in human dorsal root ganglia. Proc Natl Acad Sci USA 1995; 92: 10980-10984.
4. 4. Kramer MF, Coen DM. Quantification of transcripts from ICP4 and thymidine kinase genes in mouse ganglia latently infected with herpes simplex virus. J Virol 1995; 69: 1389-1399.
5. 5. Hay J, Ruyechan WT. Varicella-zoster virus: a different kind of herpesvirus latency? Semin Virol 1994; 5: 241-248.
6. 6. Debrus S, Sadzot-Delvaux C, Nikkels AF et al. Varicella-zoster virus gene 63 encodes an immediate-early protein that is abundantly expressed during latency. J Virol 1995; 69: 3240-3245.
7. 7. Mahalingham R, Wellish M, Cohrs R et al. Expression of protein encoded by varicella-zoster virus open reading frame 63 in latently infected human ganglionic neurons. Proc Natl Acad Sci 1996; 93: 2122-2124.
8. 8. Sabella C, Lowry P, Abbruzzi G et al. Immunization with immediate-early tegument protein (open reading frame 62) of varicella-zoster virus protects guinea pigs against virus challenge. J Virol 1993; 67: 7673-7676.
9. 9. Luby J, Ramirez-Ronda C, Rinner S et al. A longitudinal study of varicella zoster virus infections in renal transplant recipients. J Infect Dis 1977; 135: 659-663.
10. 10. Gershon A, Steinberg S, Borkowsky W et al. IgM to varicella-zoster virus: demonstration in patients with and without clinical zoster. Ped Infec Dis 1982; 1: 164-167.
11. 11. Gershon AA, Steinberg S. NIAID Collaborative Varicella Vaccine Study Group. Live attenuated varicella vaccine: protection in healthy adults in comparison to leukaemic children. J Infect Dis 1990; 161: 661-666.
12. 12. Wilson A, Sharp M, Koropchak C et al. Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation. J Infect Dis 1992; 165: 119-126.
13. 13. Takahashi M, Otsuka T, Okuno Y et al. Live vaccine used to prevent the spread of varicella in children in hospital. Lancet 1974; 2: 1288-1290.
14. 14. Tsolia M, Gershon A, Steinberg S, Gelb L. Live attenuated varicella vaccine: evidence that the virus is attenuated and the importance of skin lesions in transmission of varicella-zoster virus. J Pediatr 1990; 116: 184-189.
15. 15. LaRussa P, Lungu O, Hardy I, Gershon A, Steinberg S, Silverstein S. Restriction fragment length polymorphism of polymerase chain reaction products from vaccine and wild-type varicella-zoster virus isolates. J Virol 1992; 66: 1016-1020.
16. 16. Watson BM, Piercy SA, Plotkin SA et al. Modified chickenpox in children immunized with the Oka/ Merck varicella vaccine. Pediatrics 1993; 91: 17-22.
17. 17. Asano Y, Suga S, Yoshikawa T et al. Experience and reason: Twenty year follow up of protective immunity of the Oka live varicella vaccine. Pediatrics 1994; 94: 524-526.
18. 18. Brunell PA, Taylor-Wiedeman J, Geiser CF et al. Risk of herpes zoster in children with leukaemia: varicella vaccine compared with history of chickenpox. Pediatrics 1986; 77: 53-56.
19. 19. Merville-Louis M-P, Sadzot-Delvaux C, Delree P et al. Varicella-zoster virus infection of adult rate sensory neurons in vitro. J Virol 1989; 63: 3155-3160.
20. 20. Hammerschlag MR, Gershon A, Steinberg S et al. Herpes zoster in an adult recipient of live attenuated varicella vaccine. J Infect Dis 1989; 160: 535-537.
21. 21. Berger R, Luescher D, Just M. Enhancement of varicella-zoster-specific immune responses in the elderly by boosting with varicella vaccine. J Infect Dis 1984; 149: 647.
22. 22. Gershon A, LaRussa P, Steinberg S et al. The protective effect of immunologic boosting against zoster: an analysis in leukaemic children who were vaccinated against chickenpox. J Infect Dis 1996; 173: 450-453.
23. 23. LaRussa P, Steinberg S, Meurice F, Gershon A. Transmission of vaccine strain varicella-zoster virus from a healthy adult with vaccine-associated rash to susceptible household contacts. J Infect Dis 1997: (in press) 1997.
24. 24. Levin M, Murray M, Rotbart H, Zerbe G, White CJ, Hayward AR. Immune response of elderly individuals to a live attenuated varicella vaccine. J Infect Dis 1992; 166: 253-259.